Resistance-associated variants in chronic hepatitis C patients treated with protease inhibitors
{{output}}
Direct-acting antiviral agents in combination with pegylated interferon (PEG-IFN) and ribavirin (RBV) significantly improve sustained virologic response rate and reduce duration of therapy among both treatment-naïve and treatment-experienced patients with gen... ...
